American President Donald Trump announced that the artificial intelligence company Anthropic is starting to be viewed more favorably by his administration, suggesting the possibility of a future agreement with the Pentagon. Previously, Anthropic had been included on the list of entities considered a risk to the supply chain, and Trump ordered in February the cessation of government institutions' collaboration with it. The company contested the Department of Defense's decision, considering it a major blow. Recently, CEO Dario Amodei met with White House officials to improve relations, and Trump described the meeting as 'productive and constructive.' He mentioned that Anthropic could be very helpful and left open the possibility of an agreement with the Pentagon. The discussions focused on collaboration in areas such as cybersecurity and maintaining the United States' leadership in artificial intelligence. Anthropic requested guarantees that its technologies would not be used for the surveillance of citizens or autonomous weapons.
Sources
Trump spune că Anthropic "se redresează" și nu exclude un acord cu Pentagonul
Donald Trump afirmă că firma de inteligență artificială Anthropic "își revine" și lasă deschisă posibilitatea unui acord cu Pentagonul
Donald Trump spune că Anthropic ”se redresează” şi nu exclude un acord cu Pentagonul
Donald Trump spune că Anthropic ”se redresează” şi nu exclude un acord cu Pentagonul
Latest News
08:06
The U.S. Treasury debt has reached $40.047 trillion, exceeding CBO estimates. The rapid increase in the deficit raises concerns in the financial markets.
07:59
The Washington Post: Russians withdraw billions from banks, fearing that Putin will confiscate their deposits to finance his war
07:46
Hungary: The construction of a riverbed threshold on the Danube has raised the water level by 15-20 cm, preventing the shutdown of the turbines at the Paks nuclear power plant.
07:45
Kiev was the target of a new attack with Russian ballistic missiles. At least six people have died and 12 have been injured.
07:37
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
See more news